Cargando…

Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women

Mostrar otras versiones (1)

British Journal of Cancer (2002) 87, 1480–1480. doi:10.1038/sj.bjc.6600652 www.bjcancer.com © 2002 Cancer Research UK Correction to: British Journal of Cancer 2001; 85 (Suppl 2): 1–5. doi:10.1054/bjoc.2001.1981

Detalles Bibliográficos
Autor principal:	Jonat, W
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376299/ http://dx.doi.org/10.1038/sj.bjc.6600652

Ejemplares similares

Goserelin (Zoladex™) – its role in early breast cancer in pre- and perimenopausal women
por: Jonat, W
Publicado: (2001)

Goserelin (Zoladex) in premenopausal advanced breast cancer: duration of response and survival.
por: Dixon, A. R., et al.
Publicado: (1990)

Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
por: Cheng, Tsui Fen, et al.
Publicado: (2012)

Unsuspected Skin Metastasis of Adenocarcinoma of the Prostate in a Patient on Goserelin (Zoladex)
por: Mbaeri, Timothy Uzoma, et al.
Publicado: (2018)

A phase II trial of goserelin (Zoladex) in relapsed epithelial ovarian cancer.
por: Lind, M. J., et al.
Publicado: (1992)

Zoladex: endocrine and therapeutic effects in post-menopausal breast cancer.
por: Harris, A. L., et al.
Publicado: (1989)

Long-term Effectiveness of Adjuvant Goserelin in Premenopausal Women With Early Breast Cancer
por: Hackshaw, Allan, et al.
Publicado: (2009)

Goserelin Ovarian Ablation Failure in Premenopausal Women With Breast Cancer
por: Gupta, Aanchal, et al.
Publicado: (2021)

Combined effects of goserelin and tamoxifen on estradiol level, breast density, and endometrial thickness in premenopausal and perimenopausal women with early-stage hormone receptor-positive breast cancer: a randomised controlled clinical trial
por: Yang, H, et al.
Publicado: (2013)

The use of an LH-RH agonist (ICI 118630, Zoladex) in advanced premenopausal breast cancer.
por: Williams, M. R., et al.
Publicado: (1986)

Breast Cancer Screening in Perimenopausal Women
por: Anand, Nupur, et al.
Publicado: (2022)

Durable Response of Androgen Receptor-Positive Male Breast Cancer to Goserelin
por: Abdel Azim, Hamdy, et al.
Publicado: (2018)

The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.
por: Stein, R. C., et al.
Publicado: (1990)

Sex steroid metabolism polymorphisms and mammographic density in pre- and early perimenopausal women
por: Crandall, Carolyn J, et al.
Publicado: (2009)

Luteinizing hormone-releasing hormone analogues--the rationale for adjuvant use in premenopausal women with early breast cancer.
por: Jonat, W.
Publicado: (1998)

Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer
por: Wang, Jiayu, et al.
Publicado: (2015)

Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer
por: Noguchi, Shinzaburo, et al.
Publicado: (2015)

Update on the management of prostate cancer with goserelin acetate: patient perspectives
por: Wilson, Shandra
Publicado: (2009)

Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancer
por: Zhao, Yue, et al.
Publicado: (2021)

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer
por: Hasan, J, et al.
Publicado: (2005)

Psychiatric morbidity in perimenopausal women
por: Jagtap, Biswajit L., et al.
Publicado: (2016)

Body image in perimenopausal women
por: Szymona-Pałkowska, Katarzyna, et al.
Publicado: (2020)

Sexual Dysfunction in perimenopausal women
por: Aziz, Sadaf, et al.
Publicado: (2022)

Erratum to: The Roles of Menopausal-specific Quality of Life on Breast Cancer Screening Beliefs in Menopausal and Postmenopausal Women
por: Cheng, Winnie Lai-Sheung, et al.
Publicado: (2019)

The affect of goserelin on the QoL of women having chemotherapy for EBC: Results from the OPTION trial
por: R, Leonard, et al.
Publicado: (2020)

Erratum to: Evolving Approaches to Metastatic Breast Cancer Patients Pre-treated with Anthracycline and Taxane
por: Saji, Shigehira
Publicado: (2013)

The Swiss Perimenopause Study – study protocol of a longitudinal prospective study in perimenopausal women
por: Willi, Jasmine, et al.
Publicado: (2020)

Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer
por: Forward, D P, et al.
Publicado: (2004)

Erratum to: Cervical cancer screening of underserved women in the United States: results from the National Breast and Cervical Cancer Early Detection Program, 1997–2012
por: Tangka, Florence K. L., et al.
Publicado: (2015)

Management of endometrial modifications in perimenopausal women
por: NICULA, RENATA, et al.
Publicado: (2015)

Allostatic Load in Perimenopausal Women With Migraine
por: Alebna, Pamela, et al.
Publicado: (2021)

Prevalence, subtypes and risk factors of Blastocystis spp. infection among pre- and perimenopausal women
por: Kosik-Bogacka, Danuta, et al.
Publicado: (2021)

Erratum for “Effects of a Breast-Health Herbal Formula Supplement on Estrogen Metabolism in Pre- and Post-Menopausal Women not Taking Hormonal Contraceptives or Supplements: A Randomized Controlled Trial”
por: Laidlaw, Maggie, et al.
Publicado: (2012)

Breast cancer mortality trends in Europe among women in perimenopausal and postmenopausal age (45+)
por: Koczkodaj, Paweł, et al.
Publicado: (2019)

Abnormal Uterine Bleeding in Perimenopausal Women: The Role of Hysteroscopy and Its Impact on Quality of Life and Sexuality
por: Vitale, Salvatore Giovanni, et al.
Publicado: (2022)

Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer
por: DeMichele, Angela, et al.
Publicado: (2023)

Goserelin-Induced Chemical Burn: A Case Report and Review of the Literature
por: Mahadevan, Aditya, et al.
Publicado: (2023)

Reinduction of Hormone Sensitivity to Goserelin following Chemotherapy with Vinorelbine in Castration-Resistant Prostate Cancer
por: Grenader, Tal, et al.
Publicado: (2010)

Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnover
por: Wilson, Caroline, et al.
Publicado: (2016)

Goserelin plus endocrine treatments maintained long-term clinical benefit in a male patient with advanced breast cancer
por: Jiang, Hang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_b23s9bdse6ksh7r53s91kkk0s4